Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9881)
All Articles published online
|
Publishing Process of This Article
|
Jun 7, 2016 (publication date) through Jul 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mansour-Ghanaei F, Joukar F, Taherzadeh Z, Sokhanvar H, Hasandokht T. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial. World J Gastroenterol 2016; 22(21): 5114-5121 [PMID: 27275104 DOI: 10.3748/wjg.v22.i21.5114] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i21/5114.htm |
| Number | Citing Articles |
| 1 |
Lan Liu, Chenghao Li, Yuan Huang, Haiyan Jin. Nonsteroidal Anti-inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: a Systematic Review and Meta-analysis. Journal of Gastrointestinal Surgery 2019; 23(10): 1991 doi: 10.1007/s11605-018-3967-7
|
| 2 |
Tae Young Park, Hyun Kang, Geun Joo Choi, Hyoung-Chul Oh. Rectal NSAIDs-based combination modalities are superior to single modalities for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a network meta-analysis. The Korean Journal of Internal Medicine 2022; 37(2): 322 doi: 10.3904/kjim.2021.410
|
| 3 |
Amir H. Mohammad Alizadeh, Mohammad Abbasinazari, Behzad Hatami, Saeed Abdi, Forozan Ahmadpour, Shideh Dabir, Aida Nematollahi, Samira Fatehi, Mohammad A. Pourhoseingholi. Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis. European Journal of Gastroenterology & Hepatology 2017; 29(3): 349 doi: 10.1097/MEG.0000000000000787
|
| 4 |
Jin Ho Choi, Sang Hyub Lee. Pharmachologic Prophylaxis for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. The Korean Journal of Pancreas and Biliary Tract 2021; 26(3): 148 doi: 10.15279/kpba.2021.26.3.148
|
| 5 |
Bara El Kurdi, Zaid Imam, Abdulrahman Abonofal, Sumbal Babar, Pir Shah, Rahul Pannala, Georgios Papachristou, Juan Echavarria, Sailaja Pisipati, Sarah Jahangir, Prasad Rajalingamgari, Yu-Hui H. Chang, Vijay P. Singh. NSAIDs do not reduce severity among post-ERCP pancreatitis patients. Pancreatology 2024; 24(1): 14 doi: 10.1016/j.pan.2023.11.003
|
| 6 |
Venkata S. Akshintala, Kavin Kanthasamy, Furqan A. Bhullar, Christina J. Sperna Weiland, Ayesha Kamal, Bharati Kochar, Merve Gurakar, Saowanee Ngamruengphong, Vivek Kumbhari, Olaya I. Brewer-Gutierrez, Anthony N. Kalloo, Mouen A. Khashab, Erwin-Jan M. van Geenen, Vikesh K. Singh. Incidence, severity, and mortality of post-ERCP pancreatitis: an updated systematic review and meta-analysis of 145 randomized controlled trials. Gastrointestinal Endoscopy 2023; 98(1): 1 doi: 10.1016/j.gie.2023.03.023
|
| 7 |
Jiahui Yang, Wancong Wang, Chuan Liu, Yan Zhao, Mudan Ren, Shuixiang He. Rectal Nonsteroidal Anti-Inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention. Journal of Clinical Gastroenterology 2020; 54(4): 305 doi: 10.1097/MCG.0000000000001322
|
| 8 |
Wiqas Ahmad, Nkechi A Okam, Chenet Torrilus, Dibyata Rana, Mst. Khaleda Khatun, Nusrat Jahan. Pharmacological Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Where Do We Stand Now?. Cureus 2020; doi: 10.7759/cureus.10115
|
| 9 |
Edgar Julián Rojas-Victoria, Sara Isabel Hernández-Ruiz, Herney Andrés García-Perdomo. Effectiveness of the pharmacological therapy to prevent post ERCP acute pancreatitis: a network meta-analysis. Expert Review of Gastroenterology & Hepatology 2024; 18(4-5): 203 doi: 10.1080/17474124.2024.2345640
|
| 10 |
Fariborz Mansour-Ghanaei, Farahnaz Joukar, Ali Akbar Khalesi, Mohammadreza Naghipour, Masood Sepehrimanesh, Kourosh Mojtahedi, Sara Yeganeh, Hamid Saeidi Saedi, Saba Fakhrieh Asl. Naproxen, isosorbide dinitrate and co-administration cannot prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial. Annals of Hepato-Biliary-Pancreatic Surgery 2020; 24(3): 259 doi: 10.14701/ahbps.2020.24.3.259
|
| 11 |
Juan Pablo Román Serrano, José Jukemura, Samuel Galante Romanini, Paúl Fernando Guamán Aguilar, Juliana Silveira Lima de Castro, Isabela Trindade Torres, José Andres Sanchez Pulla, Otavio Micelli Neto, Eloy Taglieri, José Celso Ardengh. Nonsteroidal anti-inflammatory drug effectivity in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis. World Journal of Gastrointestinal Endoscopy 2020; 12(11): 469-487 doi: 10.4253/wjge.v12.i11.469
|
| 12 |
Rajarshi Mukherjee, Muhammad Awais, Wenhao Cai, Wei Huang, Peter Szatmary, Robert Sutton. Clinical Pancreatology for Practising Gastroenterologists and Surgeons. 2021; : 83 doi: 10.1002/9781119570097.ch12
|
| 13 |
Qing-Qing Shi, Guo-Xiu Huang, Wei Li, Jian-Rong Yang, Xiao-Yi Ning. Rectal nonsteroidal anti-inflammatory drugs, glyceryl trinitrate, or combinations for prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: A network meta-analysis. World Journal of Clinical Cases 2022; 10(22): 7859-7871 doi: 10.12998/wjcc.v10.i22.7859
|
| 14 |
Chong Yang, Yanting Zhao, Wentao Li, Shikai Zhu, Hongji Yang, Yu Zhang, Xi Liu, Nan Peng, Ping Fan, Xin Jin. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials. Pancreatology 2017; 17(5): 681 doi: 10.1016/j.pan.2017.07.008
|
| 15 |
Amina Ehsan. Pharmacological and non-pharmacological prophylaxis in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a narrative review. Journal of Pancreatology 2023; 6(4): 178 doi: 10.1097/JP9.0000000000000136
|
| 16 |
Yunxiao Lyu, Yunxiao Cheng, Bin Wang, Yueming Xu, Weibing Du. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0837-4
|
| 17 |
Hyoung‐Chul Oh, Hyun Kang, Tae Young Park, Geun Joo Choi, Glen A Lehman. Prevention of post‐endoscopic retrograde cholangiopancreatography pancreatitis with a combination of pharmacological agents based on rectal non‐steroidal anti‐inflammatory drugs: A systematic review and network meta‐analysis. Journal of Gastroenterology and Hepatology 2021; 36(6): 1403 doi: 10.1111/jgh.15303
|
| 18 |
B. Joseph Elmunzer. Reducing the risk of post‐endoscopic retrograde cholangiopancreatography pancreatitis. Digestive Endoscopy 2017; 29(7): 749 doi: 10.1111/den.12908
|
| 19 |
Zsolt Dubravcsik, István Hritz, Bánk Keczer, Péter Novák, Barbara Dorottya Lovász, László Madácsy. Network meta-analysis of prophylactic pancreatic stents and non-steroidal anti-inflammatory drugs in the prevention of moderate-to-severe post-ERCP pancreatitis. Pancreatology 2021; 21(4): 704 doi: 10.1016/j.pan.2021.04.006
|
| 20 |
Qian Zhang, Deng-Hao Deng, Jun Liu, Wei-Wei Chen, Juan Chen, Chao-Wu Chen. Application of non-steroidal anti-inflammatory drugs in prevention of pancreatitis after endoscopic retrograde cholangiopancreatography. World Chinese Journal of Digestology 2022; 30(4): 198 doi: 10.11569/wcjd.v30.i4.198
|